NCT02879903

Brief Summary

The aims of the present study will be identify 5 types of fimbrial subunit genotype strains in smokers and nonsmokers with periodontitis, before and after periodontal therapy. Third two periodontitis patients will be selected to these study, 16 nonsmokers and 16 smokers. Clinical and microbiological parameters were evaluated at baseline and 3 months after periodontal treatment: Plaque Index, Bleeding On Probe, Probing Depth, Gingival Recession and Clinical Attachment Level. The prevalence of P. gingivalis and fimbrial subunit gene strains will be determined by Polymerase Chain Reaction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Aug 2016

Shorter than P25 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 26, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

August 30, 2016

Status Verified

August 1, 2016

Enrollment Period

2 months

First QC Date

August 10, 2016

Last Update Submit

August 28, 2016

Conditions

Keywords

Porphyromonas gingivalisPeriodontal treatmentSmokers

Outcome Measures

Primary Outcomes (8)

  • Change from baseline Bleeding on Probe to 3 months

    Bleeding On Probe will be expressed in percentage per individual to evaluate presence of bleeding on probe.

    3 months

  • Change from Baseline Plaque Index to 3 months

    Plaque Index will be expressed in percentage per individual to evaluate presence of plaque.

    3 months

  • Change from Baseline Pocket Probing Depth to 3 months

    Pocket Probing Depth will be evaluated in millimeter. The measure will be performed at six sites per tooth using a periodontal probe.

    3 months

  • Change from Baseline Gingival Recession to 3months

    Gingival Recession will be evaluated in millimeter. The measure will be performed at six sites per tooth, from cementoenamel junction to gingival margin, using a periodontal probe.

    3 months

  • Change from Baseline Clinical Attachment level to 3 months

    Clinical Attachment Level will be evaluated in millimeter. The measure will be performed at six sites per tooth, from cementoenamel junction to the end of periodontal pocket, using a periodontal probe.

    3 months

  • Change from Baseline Biofilm to 3 months

    Pooled biofilms from each site with Probe Depth \>5mm will be collected and checked for the presence of fimbrial subunit genotype of Porphyromonas gingivalis I, II, III, IV and V by Polymerase Chain Reaction analysis. The results will be expressed by percentage of frequency of each type of fim A.

    3 months

  • Change from baseline Age to 3 months

    Age will be expressed in years.

    3 months

  • Change from Baseline Cigarette consumption to 3 months

    Time of cigarette consumption - will be expressed in years.

    3 months

Study Arms (2)

biofilm tobacco effect

EXPERIMENTAL

Group smokers - patients will receive periodontal treatment and biofilm will be collected.

Procedure: Periodontal treatmentProcedure: Microbiological collectProcedure: Questionnaire

biofilm non smoker effect

EXPERIMENTAL

Group Non Smokers - patients will receive periodontal treatment and biofilm will be collected.

Procedure: Periodontal treatmentProcedure: Microbiological collectProcedure: Questionnaire

Interventions

An experienced periodontist will be performed clinical periodontal parameters, including Plaque Index, Bleeding On Probe, Pocket Probing Depth, Gingival Recession, Clinical Attachment Level using a periodontal probe, at six sites per tooth at all teeth, excluding third molars. Quadrant scaling and root planning will be weekly performed on each patient under local anesthesia using periodontal curettes and ultrasonic scalers. The maintenance therapy will be included professional plaque control and Scaling and root planing in recurrent periodontal pockets.

biofilm non smoker effectbiofilm tobacco effect

Biofilm will be collected with the paper point to analyse presence of Porphyromonas gingivalis fimbrial subunit gene type I, II, III, IV and V.

biofilm non smoker effectbiofilm tobacco effect
QuestionnairePROCEDURE

Age will be expressed in years Sex -female and male, will be expressed in percentage. Time of cigarette consumption - will be expressed in years

biofilm non smoker effectbiofilm tobacco effect

Eligibility Criteria

Age27 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of chronic periodontitis Consumption of 10 or more cigarettes/day.

You may not qualify if:

  • Diabetes mellitus Osteoporosis Pregnant and lactating females Immune suppressive medication Phenytoin Cyclosporine Calcium channel blockers Immunotherapy or diagnosed as HIV+

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Lin X, Wu J, Xie H. Porphyromonas gingivalis minor fimbriae are required for cell-cell interactions. Infect Immun. 2006 Oct;74(10):6011-5. doi: 10.1128/IAI.00797-06.

  • Zhao L, Wu YF, Meng S, Yang H, OuYang YL, Zhou XD. Prevalence of fimA genotypes of Porphyromonas gingivalis and periodontal health status in Chinese adults. J Periodontal Res. 2007 Dec;42(6):511-7. doi: 10.1111/j.1600-0765.2007.00975.x.

  • Amano A, Kuboniwa M, Nakagawa I, Akiyama S, Morisaki I, Hamada S. Prevalence of specific genotypes of Porphyromonas gingivalis fimA and periodontal health status. J Dent Res. 2000 Sep;79(9):1664-8. doi: 10.1177/00220345000790090501.

  • Zeller I, Hutcherson JA, Lamont RJ, Demuth DR, Gumus P, Nizam N, Buduneli N, Scott DA. Altered antigenic profiling and infectivity of Porphyromonas gingivalis in smokers and non-smokers with periodontitis. J Periodontol. 2014 Jun;85(6):837-44. doi: 10.1902/jop.2013.130336. Epub 2013 Oct 23.

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Periodontal IndexSurveys and Questionnaires

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dental Health SurveysHealth SurveysData CollectionEpidemiologic MethodsInvestigative TechniquesDentistryPeriodonticsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Dentistry

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 10, 2016

First Posted

August 26, 2016

Study Start

August 1, 2016

Primary Completion

October 1, 2016

Study Completion

December 1, 2016

Last Updated

August 30, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

The result will be communicated verbally for each participant.